| Title |
Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial
|
|---|---|
| Published in |
Breast Cancer Research and Treatment, March 2006
|
| DOI | 10.1007/s10549-006-9160-9 |
| Pubmed ID | |
| Authors |
Mogens Groenvold, Peter M. Fayers, Morten Aagaard Petersen, Henning T. Mouridsen |
| Abstract |
Ovarian ablation is an effective adjuvant therapy for primary breast cancer but little is known about its quality of life impact relative to the more widely used adjuvant chemotherapy. This randomized study compared quality of life outcomes of adjuvant ovarian ablation versus cyclophosphamide, methotrexate, fluoracil (CMF) chemotherapy. |
Mendeley readers
The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 2% |
| Unknown | 57 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 10 | 17% |
| Student > Master | 9 | 16% |
| Researcher | 4 | 7% |
| Student > Ph. D. Student | 4 | 7% |
| Other | 3 | 5% |
| Other | 10 | 17% |
| Unknown | 18 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 22 | 38% |
| Nursing and Health Professions | 6 | 10% |
| Psychology | 5 | 9% |
| Agricultural and Biological Sciences | 2 | 3% |
| Engineering | 2 | 3% |
| Other | 4 | 7% |
| Unknown | 17 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 February 2012.
All research outputs
#5,611,796
of 26,017,215 outputs
Outputs from Breast Cancer Research and Treatment
#1,060
of 5,058 outputs
Outputs of similar age
#16,191
of 88,228 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#4
of 22 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,058 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 88,228 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.